Editorial: Biomarkers of response to interventions in psychiatry

Mental disorders remain among the leading causes of disability and premature mortality worldwide, with a growing burden across both high-income and low-and middle-income countries. Despite substantial advances in pharmacological and psychosocial treatments, clinical decision-making in psychiatry continues to rely heavily on subjective symptom reports and trial-and-error approaches. This limitation has fueled increasing interest